Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-039148

Chief Executive Officer sold 100,000 shares at an average $38.81 ($3,881,017)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2020-06-25 Sale −99,977 $38.81 $3,880,107 2,605,260 D: show line 1 in the form
Anzalone Christopher Richard Chief Executive Officer 2020-06-25 Sale −23 $39.55 $910 2,605,237 D: show line 2 in the form
Open-market sales · 100,000 sh · avg $38.81 · $3,881,017
Loading xslF345X03/doc4.xml…